PEAK6 Investments’s Bionano Genomics BNGO Stock Holding History

PEAK6 Investments’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3	Closed	-$15K	–	5183
2021 Q2	$15K	Buy	+3	New	+$11.8K	﹤0.01%	4769

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

PEAK6 Investments's BNGO Position: Q4 2021 in Review

PEAK6 Investments sold out of Bionano Genomics (BNGO) in Q4 2021, closing a stake of 21 shares — an estimated $69K sold.

PEAK6 Investments first reported a position in BNGO in Q2 2021 and held it in 2 quarters. The position peaked at $116K in Q2 2021. 149 funds tracked by Wall St. Rank hold BNGO as of Q4 2021.

PEAK6 Investments reported no remaining Bionano Genomics position as of Q4 2021 after selling out during the quarter.
PEAK6 Investments sold 21 Bionano Genomics shares in Q4 2021, an estimated $69K.
PEAK6 Investments first reported a position in Bionano Genomics in Q2 2021 and held it in 2 quarters.
PEAK6 Investments's Bionano Genomics position peaked at $116K in Q2 2021.
149 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2021.

Based on PEAK6 Investments's 13F filing for Q4 2021, filed 11 Feb 2022.